Pironti, M. (2026) “CO69 | <i>PRDM1</i> and <i>TNFAIP3</i> copy number losses predict a shorter time to first treatment in igm gammopathies: new insights from the Fondazione Italiana Linfomi ‘BIO-WM’ trial: <a href="https://haematologica.org/search/search?query=M.+Pironti">M. Pironti</a>¹, <a href="https://haematologica.org/search/search?query=S.+Ferrero">S. Ferrero</a>^1|2, <a href="https://haematologica.org/search/search?query=S.+Zimbellini">S. Zimbellini</a>³, <a href="https://haematologica.org/search/search?query=L.+Marcheselli">L. Marcheselli</a>⁴, <a href="https://haematologica.org/search/search?query=S.+Russo">S. Russo</a>¹, <a href="https://haematologica.org/search/search?query=E.+Genuardi">E. Genuardi</a>¹, <a href="https://haematologica.org/search/search?query=C.+Varraso">C. Varraso</a>³, <a href="https://haematologica.org/search/search?query=F.+Cavallo">F. Cavallo</a>^1|2, <a href="https://haematologica.org/search/search?query=I.+Dogliotti">I. Dogliotti</a>², <a href="https://haematologica.org/search/search?query=E.+Cappello">E. Cappello</a>³, <a href="https://haematologica.org/search/search?query=S.+Ragaini">S. Ragaini</a>¹, <a href="https://haematologica.org/search/search?query=G.+Favrin">G. Favrin</a>³, <a href="https://haematologica.org/search/search?query=A.+Ferrari">A. Ferrari</a>⁵, <a href="https://haematologica.org/search/search?query=M.+Coscia">M. Coscia</a>⁶, <a href="https://haematologica.org/search/search?query=C.+Jimenez">C. Jimenez</a>⁷, <a href="https://haematologica.org/search/search?query=B.+M.+Granelli">B. M. Granelli</a>⁸, <a href="https://haematologica.org/search/search?query=L.+Laurenti">L. Laurenti</a>⁹, <a href="https://haematologica.org/search/search?query=E.+Cencini">E. Cencini</a>¹⁰, <a href="https://haematologica.org/search/search?query=S.+Tommassetti">S. Tommassetti</a>¹¹, <a href="https://haematologica.org/search/search?query=D.+Marino">D. Marino</a>¹², <a href="https://haematologica.org/search/search?query=G.+Loseto">G. Loseto</a>¹³, <a href="https://haematologica.org/search/search?query=M.+Marchetti">M. Marchetti</a>¹⁴, <a href="https://haematologica.org/search/search?query=F.+Russo">F. Russo</a>¹⁵, <a href="https://haematologica.org/search/search?query=A.+Sica">A. Sica</a>¹⁶, <a href="https://haematologica.org/search/search?query=J.+Olivieri">J. Olivieri</a>¹⁷, <a href="https://haematologica.org/search/search?query=E.+Amaducci">E. Amaducci</a>¹, <a href="https://haematologica.org/search/search?query=C.+Picone">C. Picone</a>³, <a href="https://haematologica.org/search/search?query=B.+Bruno">B. Bruno</a>^1|2, <a href="https://haematologica.org/search/search?query=M.+Varettoni">M. Varettoni</a>³, <a href="https://haematologica.org/search/search?query=D.+Drandi">D. Drandi</a>¹ | <i>¹Department of Molecular Biotechnology and health sciences, Hematology Division, University of Torino; ²Division of Hematology, A. O. U. Città della Salute e della Scienza di Torino, Torino; ³Fondazione IRCCS Policlinico San Matteo; ⁴Fondazione Italiana Linfomi; ⁵Ematologia - AO Arcispedale Santa Maria Nuova - IRCCS; ⁶Department of Medicine and Surgery, University of Insubria and Division of Hematology ASST Sette Laghi; ⁷Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca CIBERONC and Center for Cancer Research-IBMCC; ⁸ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia; ⁹Ematologia - Università Cattolica S. Cuore; ¹⁰U. O. C. Ematologia, AOU Senese; ¹¹Ematologia - Ospedale degli Infermi di Rimini; ¹²Oncologia 1 - I. R. C. C. S. Istituto Oncologico Veneto; ¹³U. O. C Ematologia, IRCCS Istituto Tumori Giovanni Paolo II; ¹⁴S. O. S. Ematologia, Ospedale Cardinal Massaia; ¹⁵AOU di Parma - UOC Ematologia e CTMO; ¹⁶AOU Universitа degli Studi della Campania Luigi Vanvitelli - Oncologia Medica ed Ematologia; ¹⁷Azienda Sanitaria Universitaria Friuli Centrale - SOC Clinica Ematologica</i&gt;”, Haematologica. Pavia, Italy, 111(s1). doi: 10.3324/haematol.2026.s1.71.